The BIO Ventures for Global Health AC3T initiative

Bookmark and Share
Published: 7 Feb 2020
Views: 851
Rating:
Save
Jennifer Dent - CEO BIO Ventures for Global Health (BVGH), Seattle, USA

Jennifer Dent speaks to ecancer at the 2019 AORTIC conference in Maputo about the work of BIO Ventures for Global Health (BVGH).

In this video, she discusses AC3T (the African Consortium for Cancer Clinical Trails), which looks at the possibility to conduct cancer clinical trials at 25 hospitals across Africa.

Jennifer outlines why this representation in clinical trails is important, and which countries will be involved.